All Stories

  1. Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII
  2. A Simple, Efficient, and Sensitive Method for Simultaneous Detection of Anti-HIV Drugs Atazanavir, Ritonavir, and Tenofovir by Use of Liquid Chromatography-Tandem Mass Spectrometry
  3. Long-acting three-drug combination anti-HIV nanoparticles enhance drug exposure in primate plasma and cells within lymph nodes and blood
  4. Aerosol-Stable Peptide-Coated Liposome Nanoparticles: A Proof-of-Concept Study with Opioid Fentanyl in Enhancing Analgesic Effects and Reducing Plasma Drug Exposure
  5. Evaluation of Atazanavir and Darunavir Interactions with Lipids for Developing pH-Responsive Anti-HIV Drug Combination Nanoparticles
  6. O3‐14‐06: AXONAL TRANSPORT AND CYTOSKELETAL THERAPEUTICS IN ALZHEIMER'S DISEASE
  7. Interactions of Indocyanine Green and Lipid in Enhancing Near-Infrared Fluorescence Properties: The Basis for Near-Infrared Imaging in Vivo
  8. Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery Systems
  9. Trends in Translational Medicine and Drug Targeting and Delivery: New Insights on an Old Concept—Targeted Drug Delivery with Antibody–Drug Conjugates for Cancers
  10. Biotechnology and Biopharmaceuticals
  11. VACCINES
  12. pH-Responsive Artemisinin Derivatives and Lipid Nanoparticle Formulations Inhibit Growth of Breast Cancer Cells In Vitro and Induce Down-Regulation of HER Family Members
  13. Enhanced Anti-HIV Efficacy of Indinavir After Inclusion in CD4-Targeted Lipid Nanoparticles
  14. Ho RJ, Chien JY. 2012. Drug Delivery Trends in Clinical Trials and Translational Medicine: Growth in Biologic Molecule Development and Impact on Rheumatoid Arthritis, Crohn's Disease, and Colitis. J Pharm Sci 101:2668–2674.
  15. Report of the 2011-2012 AACP Special Advisory Committee on Research and Graduate Education
  16. Drug Delivery Trends in Clinical Trials and Translational Medicine: Growth in Biologic Molecule Development and Impact on Rheumatoid Arthritis, Crohn's Disease, and Colitis
  17. Design and Characterization of Novel Peptide-Coated Lipid Nanoparticles for Targeting Anti-HIV Drug to CD4 Expressing Cells
  18. Elucidation of the time course of adenosine deaminase APOBEC3G and viral infectivity factor vif in HIV‐2287‐infected infant macaques
  19. Editorial
  20. Pharmacogenetics of Intravenous and Oral Busulfan in Hematopoietic Cell Transplant Recipients
  21. Enhanced Analgesic Responses After Preferential Delivery of Morphine and Fentanyl to the Olfactory Epithelium in Rats
  22. Development and characterization of transgenic mouse models for conditional gene knockout in the blood–brain and blood-CSF barriers
  23. Effects of Localized Hydrophilic Mannitol and Hydrophobic Nelfinavir Administration Targeted to Olfactory Epithelium on Brain Distribution
  24. Drug Delivery Trends in Clinical Trials and Translational Medicine: Evaluation of Pharmacokinetic Properties in Special Populations
  25. Novel Gd Nanoparticles Enhance Vascular Contrast for High-Resolution Magnetic Resonance Imaging
  26. A Novel MDR1 GT1292-3TG (Cys431Leu) Genetic Variation and Its Effect on P-glycoprotein Biologic Functions
  27. AIDS Treatment with Novel Anti-HIV Compounds Improved by Nanotechnology
  28. Drug delivery trends in clinical trials and translational medicine: Updated analysis of ClinicalTrials.gov database
  29. MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents
  30. Effects of photoactivated 5-aminolevulinic acid hexyl ester on MDR1 over-expressing human uterine sarcoma cells☆
  31. Combining Drug and Immune Therapy: A Potential Solution to Drug Resistance and Challenges of HIV Vaccines?
  32. Drug Delivery Trends in Clinical Trials and Translational Medicine
  33. pH-Dependent Interactions of Indinavir and Lipids in Nanoparticles and Their Ability to Entrap a Solute
  34. Effects of lipid association on lomustine (CCNU) administered intracerebrally to syngeneic 36B-10 rat brain tumors
  35. A Novel MDR1 G1199T Variant Alters Drug Resistance and Efflux Transport Activity of P-Glycoprotein in Recombinant Hek Cells
  36. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P‐gp substrate transport in recombinant LLC‐PK1 cells
  37. Feasibility of Weekly HIV Drug Delivery to Enhance Drug Localization in Lymphoid Tissues Based on Pharmacokinetic Models of Lipid-Associated Indinavir
  38. Recent Developments in Drug Targets and Delivery of Anti-HIV Drugs
  39. Optimization of Lipid-Indinavir Complexes for Localization in Lymphoid Tissues of HIV-infected Macaques
  40. Response to
  41. Special Challenges of Rearing Infant Macaques Infected with Lentivirus (SIV, HIV, SHIV)
  42. MDR1 G1199A polymorphism alters permeability of HIV protease inhibitors across P-glycoprotein-expressing epithelial cells
  43. The Impact of Pharmacologic and Genetic Knockout of P-Glycoprotein on Nelfinavir Levels in the Brain and Other Tissues in Mice
  44. Characterization of the humanMDR1 gene
  45. An RT-PCR-based Strategy to Estimate Full-Length CYP2D6 mRNA Copy Number
  46. HIV in central nervous system and behavioral development
  47. Development and characterization of a recombinant madin-darby canine kidney cell line that expresses rat multidrug resistance-associated protein 1 (rMRP1)
  48. Preface [Hot topic: Research on the Role of Membrane Transporters in Drug Disposition: Present Challenges and Future Directions (Guest Editors: Rodney J.Y. Ho and Danny D. Shen)]
  49. Augmentation of Cell-Mediated Immunity to Virus
  50. Design and Characterization of a Novel Lipid‐DNA Complex that Resists Serum‐induced Destabilization
  51. Lipid–Drug Association Enhanced HIV-1 Protease Inhibitor Indinavir Localization in Lymphoid Tissues and Viral Load Reduction: A Proof of Concept Study in HIV-2287-Infected Macaques
  52. Biotechnology and Biopharmaceuticals
  53. Cloning and characterization of the rat multidrug resistance-associated protein 1
  54. The Role of Drug-Lipid Interactions on the Disposition of Liposome-Formulated Opioid Analgesics In Vitro and In Vivo
  55. Trends and Developments in Liposome Drug Delivery Systems
  56. Basic Science (22)
  57. Basic Science (22)
  58. Suppression of Maternal Virus Load With Zidovudine, Didanosine, and Indinavir Combination Therapy Prevents Mother-to-Fetus HIV Transmission in Macaques
  59. Suppression of Maternal Virus Load With Zidovudine, Didanosine, and Indinavir Combination Therapy Prevents Mother-to-Fetus HIV Transmission in Macaques
  60. The Effects of Intrathecal Morphine Encapsulated in l- and d-Dipalmitoylphosphatidyl Choline Liposomes on Acute Nociception in Rats
  61. The Effects of Intrathecal Morphine Encapsulated in l- and d-Dipalmitoylphosphatidyl Choline Liposomes on Acute Nociception in Rats
  62. Challenges in the development of an effective HIV vaccine: Current approaches and future directions
  63. Formulation of HIV-envelope protein with lipid vesicles expressing ganglioside GM1 associated to cholera toxin B enhances mucosal immune responses
  64. Association With Oleic Acid Vesicles Enhances Manganese III Mesoporphyrin Absorption and Biliary Elimination in Rats
  65. Intestinal absorption of Mn-mesoporphyrin in a small bowel sac system: Effect of oleic acid
  66. Augmentation of cell-mediated immunotherapy against herpes simplex virus by interleukins: comparison of in vivo effects of IL-2 and IL-7 on adoptively transferred T cells
  67. Development of a chronically catheterized maternal‐fetal macaque model to study in utero mother‐to‐fetus HIV transmission: A preliminary report
  68. Application of Liposomes in Antigen Presentation and Cytokine Delivery
  69. Magnetic resonance imaging of the hepatobiliary system: Intestinal absorption studies of manganese mesoporphyrin
  70. Antinociception and Side Effects of L‐and D‐Dipalmitoylphosphatidyl Choline Liposome‐Encapsulated Alfentanil after Spinal Delivery in Rats*
  71. Simian Immunodeficiency Virus Infection of Macaque Primary Placental Cells
  72. Touch-evoked Agitation Produced by Spinally Administered Phospholipid Emulsion and Liposomes in Rats 
  73. Interaction of Manganese-Mesoporphyrin with Oleic Acid Vesicles
  74. Cytokines as Vaccine Adjuvants
  75. Antinociception and Side Effects of Liposome-Encapsulated Alfentanil After Spinal Delivery in Rats
  76. Metabolism of 3′-azido-3′-deoxythymidine (AZT) in human placentae trophoblasts and Hofbauer cells
  77. Characterization of Macaque placental trophoblast and Hofbauer cell response to Zidovudine
  78. Disposition of antigen-presenting liposome in vivo: Effect on presentation of herpes simplex virus antigen rgD
  79. Biological response of recombinant interleukin-7 on herpes simplex virus infection in guinea-pigs
  80. Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea-pigs
  81. Physical and biological characterization of antigen presenting liposome formulations: Relative efficacy for the treatment of recurrent genital HSV-2 in guinea pigs
  82. Kinetic and ultrastructural studies of interactions of target-sensitive immunoliposomes with herpes simplex virus
  83. Nonenzymatic hydrolysis of phosphatidylcholine prepared as liposomes and mixed micelles
  84. Trypsin induced destabilization of liposomes composed of dioleoylphosphatidylethanolamine and glycophorin
  85. Target-sensitive immunoliposomes: preparation and characterization
  86. Destabilization of target-sensitive immunoliposomes by antigen binding — A rapid assay for virus
  87. Analysis of Coenzyme Q<SUB>10</SUB> Content in Human Plasma and Other Biological Samples